The WASH study (Warfarin/Aspirin Study in Heart failure) rationale, design and end-points
- 1 March 1999
- journal article
- Published by Wiley in European Journal of Heart Failure
- Vol. 1 (1), 95-99
- https://doi.org/10.1016/s1388-9842(98)00007-5
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Baseline clinical characteristics of patients recruited into the assessment of treatment with lisinopril and survival studyEuropean Journal of Heart Failure, 1999
- Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trialThe Lancet, 1998
- Screening For Left Ventricular Dysfunction and Chronic Heart FailureDisease Management and Health Outcomes, 1997
- Mode of death in chronic heart failure: A request and proposition for more accurate classificationEuropean Heart Journal, 1996
- Should all patients with atrial fibrillation receive warfarin? Evidence from randomized clinical trialsEuropean Heart Journal, 1996
- Is aspirin safe for patients with heart failure?Heart, 1995
- Endothelium-Dependent Modulation of Venoconstriction to Sarafotoxin S6c in Human Veins In VivoJournal of Cardiovascular Pharmacology, 1995
- Frequency of magnetic resonance signal abnormalities of the brain in patients aged <50 years with idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 1992
- The Impact of Long-term Warfarin Therapy on Quality of LifeArchives of Internal Medicine, 1991
- Brain magnetic resonance imaging and neuropsychologic evaluation of patients with idiopathic dilated cardiomyopathy.Stroke, 1991